Xenon Pharmaceuticals
XENE
XENE
132 hedge funds and large institutions have $1.44B invested in Xenon Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.27% more ownership
Funds ownership: 92.44% → 94.71% (+2.3%)
0% less capital invested
Capital invested by funds: $1.44B → $1.44B (-$1.55M)
89% less call options, than puts
Call options by funds: $557K | Put options by funds: $5.25M
Holders
132
Holding in Top 10
8
Calls
$557K
Puts
$5.25M
Top Buyers
| 1 | +$40.5M | |
| 2 | +$27.8M | |
| 3 | +$17.4M | |
| 4 |
Goldman Sachs
New York
|
+$16.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$9.57M |
Top Sellers
| 1 | -$51.7M | |
| 2 | -$25.9M | |
| 3 | -$7.03M | |
| 4 |
Bank of New York Mellon
New York
|
-$6.49M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$5.78M |